Mouse nuclear myosin I knock-out shows interchangeability and redundancy of myosin isoforms in the cell nucleus

PLoS One. 2013 Apr 11;8(4):e61406. doi: 10.1371/journal.pone.0061406. Print 2013.

Abstract

Background: Nuclear myosin I (NM1) is a nuclear isoform of the well-known "cytoplasmic" Myosin 1c protein (Myo1c). Located on the 11(th) chromosome in mice, NM1 results from an alternative start of transcription of the Myo1c gene adding an extra 16 amino acids at the N-terminus. Previous studies revealed its roles in RNA Polymerase I and RNA Polymerase II transcription, chromatin remodeling, and chromosomal movements. Its nuclear localization signal is localized in the middle of the molecule and therefore directs both Myosin 1c isoforms to the nucleus.

Methodology/principal findings: In order to trace specific functions of the NM1 isoform, we generated mice lacking the NM1 start codon without affecting the cytoplasmic Myo1c protein. Mutant mice were analyzed in a comprehensive phenotypic screen in cooperation with the German Mouse Clinic. Strikingly, no obvious phenotype related to previously described functions has been observed. However, we found minor changes in bone mineral density and the number and size of red blood cells in knock-out mice, which are most probably not related to previously described functions of NM1 in the nucleus. In Myo1c/NM1 depleted U2OS cells, the level of Pol I transcription was restored by overexpression of shRNA-resistant mouse Myo1c. Moreover, we found Myo1c interacting with Pol II. The ratio between Myo1c and NM1 proteins were similar in the nucleus and deletion of NM1 did not cause any compensatory overexpression of Myo1c protein.

Conclusion/significance: We observed that Myo1c can replace NM1 in its nuclear functions. Amount of both proteins is nearly equal and NM1 knock-out does not cause any compensatory overexpression of Myo1c. We therefore suggest that both isoforms can substitute each other in nuclear processes.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Blotting, Western
  • Cell Nucleus / metabolism*
  • DNA Primers / genetics
  • Genotype
  • Immunoprecipitation
  • Mice
  • Mice, Knockout
  • Myosin Type I / genetics*
  • Myosin Type I / metabolism*
  • Phenotype*
  • Plasmids / genetics
  • Protein Isoforms / genetics
  • Protein Isoforms / metabolism
  • Reverse Transcriptase Polymerase Chain Reaction

Substances

  • DNA Primers
  • Myo1c protein, mouse
  • Protein Isoforms
  • Myosin Type I

Grants and funding

This study has been supported by the Grant Agency of Czech Republic (Reg. No. 204/09/4048 and Reg. No. P305/11/2232, http://www.gacr.cz/), by the Technology Agency of Czech Republic (Reg. No. TE01010118, http://www.tacr.cz/), by the Ministry of Education, Youth and Sports of the Czech Republic (Reg. No. LH12143, http://www.msmt.cz/), by the institutional grant AV0Z50520514 (www.img.cas.cz), by the Grant Agency of the Charles University (Reg. No. 253189, www.cuni.cz) and by the Austrian Federal Ministry of Science and Research (BM.W_Fa, GEN-AU II/III ″Austromouse″, http://www.bmwf.gv.at). Phenotyping of NM1 KO mice in the German Mouse Clinic has been supported by grants from the European Community (EUMODIC LSHG-2006-037188, http://www.eumodic.org/) and from the Bundesministerium für Bildung und Forschung (NGFN-Plus: 01GS0850, 01GS0851; Infrafrontier 01KX1012, http://www.bmbf.de/) to the GMC and to the German Center for Diabetes Research (DZD e.V.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.